Cargando…
Patient Experience of Flunarizine for Vestibular Migraine: Single Centre Observational Study
Vestibular migraine (VM) is a leading cause of episodic vertigo, affecting up to 1% of the general population. Despite established diagnostic criteria, there is currently no evidence-based approach for acute treatment of VM, with treatment recommendations generally extrapolated from studies on class...
Autores principales: | Rashid, Sk Mamun Ur, Sumaria, Sheetal, Koohi, Nehzat, Arshad, Qadeer, Kaski, Diego |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028524/ https://www.ncbi.nlm.nih.gov/pubmed/35447947 http://dx.doi.org/10.3390/brainsci12040415 |
Ejemplares similares
-
Head shaking does not alter vestibulo ocular reflex gain in vestibular migraine
por: Patel, Priyani, et al.
Publicado: (2022) -
The Efficacy of Venlafaxine, Flunarizine, and Valproic Acid in the Prophylaxis of Vestibular Migraine
por: Liu, Fenye, et al.
Publicado: (2017) -
Vestibular migraine treatment: a comprehensive practical review
por: Smyth, Duncan, et al.
Publicado: (2022) -
Clinician’s perspectives in using head impulse-nystagmus-test of skew (HINTS) for acute vestibular syndrome: UK experience
por: Warner, Charlotte L, et al.
Publicado: (2021) -
Abnormal visuo-vestibular interactions in vestibular migraine: a cross sectional study
por: Bednarczuk, Nadja F, et al.
Publicado: (2019)